President Donald Trump and the pharmaceutical giant Pfizer announced an agreement Tuesday to lower medication costs for Medicaid patients, advancing Trump’s “Most Favored Nation” pricing effort to reduce the cost of American prescription drugs.
Trump announced alongside Pfizer CEO Albert Bourla in the Oval Office the pharmaceutical giant would implement a series of new policies to reduce drug prices for American patients as early as the beginning of next year.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.